Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-029514

Chief Executive Officer bought 995 shares at $6.99 ($6,955)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-05-13 Purchase : show line 1 in the form +995 $6.99 $6,955 64,185 D
Open-market purchases · 995 sh · avg $6.99 · $6,955
Loading xslF345X03/doc4.xml…